The case, which was filed in the US District Court for the Eastern District of New York, alleges that the defendants violated anti-trust rules by fixing prices on dental equipment and supplies, as well as other claims.
The Melville, N.Y.-based company said that it expects to incur a charge of $38.5 million in pre-tax money, or 19¢ per share, to settle the case.
The charges are slated to go on the books for the company’s third quarter, though the settlement is subject to a definitive agreement amongst all engaged parties, as well as court approval. Co-defendants Patterson (NSDQ:PDCO) and Benco Dental also expect to settle, Henry Schein said in its press release.
“We categorically and emphatically deny any wrongdoing, and we have made a business decision in the best interests of the Company to engage in settlement discussions to avoid long, distracting litigation and the additional use of resources. We have a long history of serving customers with integrity and honesty, and we have earned our reputation for doing business ethically in a competitive business environment,” board chair & CEO Stanley Bergman said in a press release.
Shares in Henry Schein have fallen 4.6% so far today, at $77.34 as of 11:04 a.m. EDT.
In February, the U.S. Federal Trade Commission filed a complaint against Henry Schein, Patterson and Benco alleging violations of US antitrust law by conspiring to refuse to provide discounts to or to serve buying groups representing dental practitioners.
The three companies, which the FTC claims control more than 85% of all dental product distributor sales in the US, face allegations that they denied independent benefits of such buying groups to dental practices mostly composed of small businesses, including solo or small groups of dentists.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.